Why Russia, Specifically

Desomorphine itself isn't new — it was patented in the US in the 1930s (branded Permonid) as a fast, short-acting analgesic and largely abandoned because that short duration made it a poor clinical opioid. It sat unused for 70+ years.

It resurfaced in Russia in the mid-2000s for a structural reason, not a chemical one: methadone and buprenorphine — the standard opioid substitution therapies used almost everywhere else — are illegal in Russia, a policy position the Russian government has held on the grounds that substitution therapy just substitutes one addiction for another. So a population of heroin users facing a supply squeeze (heroin routes tightening, prices rising) had no legal OST off-ramp and no accessible pharmaceutical opioid to fall back on. What they did have was over-the-counter codeine tablets. Home synthesis of a heroin-like drug from codeine filled the vacuum that methadone fills everywhere else — hence "pre-methadone hell" is a fair description: it's what happens when the substitution-therapy safety net doesn't exist and codeine is still on a pharmacy shelf.

The ~2 Hour Half-Life Problem

Desomorphine's effects last roughly 2 hours, sometimes less — compared to heroin's 4-6 hour functional duration. Pharmacologically it's more potent than morphine, but that potency comes with a much narrower window before withdrawal symptoms begin.

The consequence is behavioral, not just chemical: users report dosing 4-6+ times a day just to stay ahead of withdrawal, versus 1-3 times for heroin. Every dose is another injection, and given the profile below, every injection is another exposure to whatever didn't get separated out in the cook. The short half-life isn't a side detail — it's the mechanism that turns "occasional toxic exposure" into "repeated toxic exposure on a near-hourly cycle."

Why the Contamination Is Structural, Not Accidental

I'm not going to lay out the synthesis route — that crosses into providing drug-manufacturing instructions, which I won't do regardless of the context. But the reason the tissue damage happens is worth understanding, because it explains why "just be more careful" was never a viable harm-reduction answer here:

• The starting reagents used in home desomorphine synthesis are industrial/household chemicals never intended for injection — things like solvents and reactive halogens.
• Underground kitchen conditions have no purification step equivalent to pharmaceutical processing (no recrystallization, no chromatography, no quality testing). What comes out is a crude reaction mixture, not an isolated compound.
• Users typically inject that crude mixture with minimal or no further cleanup, because time pressure (see: 2-hour half-life) works against careful purification.

So the person isn't injecting desomorphine with trace impurities — they're injecting desomorphine suspended in leftover reaction byproducts. Those byproducts are directly caustic to vascular endothelium and soft tissue, which is why the damage pattern is vascular/dermal necrosis rather than the overdose/respiratory-depression profile you'd associate with opioid toxicity alone. It's less "this opioid is dangerous" and more "this delivery vehicle is a chemical injury waiting to happen, and the opioid is just what's keeping people injecting it."

Where It Actually Sits in the Literature

Worth noting for anyone using this for the forum: a lot of the "average life expectancy after starting = 2-3 years" figures that circulated with the 2010-2013 media coverage came from a small number of clinical case reports and Russian addiction-treatment center statements, not a peer-reviewed cohort study. The tissue damage and rapid deterioration are real and well documented in case series; the specific mortality timeline is closer to informed clinical estimate than hard epidemiology. Might be worth a caveat line if you're citing a number in the post.